Bright Minds Biosciences Inc. (NASDAQ:DRUG - Get Free Report) major shareholder Cormorant Asset Management, Lp bought 372,591 shares of the business's stock in a transaction on Tuesday, October 15th. The shares were purchased at an average cost of $5.53 per share, for a total transaction of $2,060,428.23. Following the completion of the purchase, the insider now owns 825,000 shares in the company, valued at approximately $4,562,250. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.
Bright Minds Biosciences Stock Down 24.7 %
Shares of NASDAQ:DRUG opened at $21.70 on Friday. The company's fifty day moving average is $2.88 and its two-hundred day moving average is $1.73. Bright Minds Biosciences Inc. has a 12-month low of $0.93 and a 12-month high of $38.49. The company has a market cap of $96.22 million, a P/E ratio of -21.49 and a beta of 1.56.
True paradigm shift
From Porter & Company | Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.
Bright Minds Biosciences (NASDAQ:DRUG - Get Free Report) last posted its quarterly earnings results on Wednesday, August 14th. The company reported $0.04 earnings per share for the quarter.
Bright Minds Biosciences Company Profile
(
Get Free Report)
Bright Minds Biosciences Inc, a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
